India Infusion Pumps Market Size Booming at Significant CAGR of 8.26% During 2023-2029
India infusion pumps market is gaining traction because of the government initiatives to provide affordable and accessible healthcare and rising incidence of chronic diseases.

Report Ocean, a leading strategic consulting and market research firm, in its recent study, expects the India infusion pumps market size to grow at a CAGR of 8.26% during the forecast period between 2023 and 2029. An increase in the incidence of chronic illnesses is among the key driving factors for the India infusion pumps market. Several applications, including the management of diabetes and chemotherapy, currently make substantial use of infusion pumps. It is also expected that the aging population would further drive the growth of the infusion pump industry in the country. A rise in surgical operations will also spur the demand for infusion pumps during the forecast period.

India Infusion Pumps Market - Overview:
An infusion pump is a medical device that administers fluids into a patient's body in precisely measured amounts, including nutrients and drugs. Infusion pumps are frequently used in clinical settings, including hospitals, nursing homes, and private residences. The design of the infusion pump allows it to administer either large or small doses of nutrition and drugs. The drugs include antibiotics, insulin, and other hormones; chemotherapeutic treatments; and painkillers that are infused. Conventional infusion pumps include syringe infusion pumps, disposable pumps, large-volume pumps, and elastomeric pumps.

India Infusion Pumps Market - By End User:
Based on end user, the India infusion pumps market is segmented into hospitals & clinics, home care settings, ambulatory care settings, and others. Due to the significant number of outpatient visits for the diagnosis and treatment of different chronic illnesses as well as the availability of skilled employees to operate such devices, hospitals, and clinics hold the highest market share. However, home care settings are projected to register the highest growth rate during the forecast period. The segment's expansion is being significantly fueled by an increasing desire to treat chronic patients at home.

Impact of COVID-19 on the India Infusion Pumps Market
The COVID-19 pandemic had a mixed impact on the India infusion pumps market. The pandemic had a detrimental effect on the market, as it disrupted supply chains, restricted access to healthcare services, and created economic uncertainty. Import limitations led to shortages of infusion pumps and other diabetes care items, which had a severe impact on patients' access to these devices. People with diabetes found it difficult to get the appropriate care, such as insulin pump therapy, due to limited access to healthcare facilities. However, the pandemic led to a spike in demand for infusion pumps in home care settings, which boosted the growth of the market.

Competitive Landscape:
Major players operating in the India infusion pumps market include: BD, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Terumo Corporation, Roche Diagnostics India Pvt Ltd, Johnson & Johnson Private Limited, Braun Melsungen AG, Smiths Medical India Pvt Ltd, Nipro India Corporation Pvt Ltd, Zynova Pharmaceuticals Pvt Ltd, NIKKISO CO., LTD., Mindray Medical India Pvt Ltd, and Stryker Corporation

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the India Infusion Pumps Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the India Infusion Pumps Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.